CROX Crocs, Inc.
Rubber & Plastics Footwear · Nasdaq · SEC CIK 1334036 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY0.7%
TTM net income YoY263.9%
TTM EPS YoY358.3%
Revenue 3-yr CAGR1.3%
Net income 3-yr CAGR-0.6%
Margins
Gross margin59.4%
Operating margin22.6%
Net margin16.2%
FCF margin18.4%
EBITDA margin24.5%
Returns
ROE49.1%
ROA15.5%
ROIC (approx.)29.0%
Asset turnover0.96x
Leverage & solvency
Liabilities / assets68.6%
Debt / equity0.96x
Current ratio1.44x
Interest coverage11.46x
Cash quality & payout
Operating cash flow / net income1.22x
Accruals ratio-3.5%
Payout ratio—
Capex / revenue1.5%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $4.04B | $4.10B |
| Cost of revenue | $1.68B | $1.69B |
| Gross profit | $2.36B | $2.41B |
| R&D expense | $29.60M | $25.60M |
| SG&A expense | $1.47B | $1.36B |
| Operating income | $149.51M | $1.02B |
| Interest expense | $88.29M | $109.26M |
| Pretax income | $72.98M | $910.59M |
| Income tax | $154.18M | -$39.49M |
| Net income | -$81.20M | $950.07M |
| EBITDA | $228.80M | $1.09B |
| EPS (basic) | -1.50 | 16.00 |
| EPS (diluted) | -1.50 | 15.88 |
| Weighted avg. shares (diluted) | 54.21M | 59.83M |
| Balance sheet | ||
| Cash & equivalents | $130.35M | $183.68M |
| Receivables | $278.19M | $257.66M |
| Inventory | $368.69M | $356.25M |
| Current assets | $885.88M | $872.27M |
| PP&E, net | $238.19M | $244.34M |
| Goodwill | $404.69M | $711.49M |
| Intangibles | $1.32B | $1.78B |
| Total assets | $4.17B | $4.81B |
| Current liabilities | $700.13M | $740.21M |
| Short-term debt | $0 | $0 |
| Long-term debt | $1.23B | $1.35B |
| Total debt | $1.23B | $1.35B |
| Total liabilities | $2.88B | $2.98B |
| Shareholders' equity | $1.29B | $1.84B |
| Net debt | $1.10B | $1.17B |
| Shares outstanding | 50.20M | 56.50M |
| Cash flow statement | ||
| Operating cash flow | $710.43M | $992.49M |
| Capital expenditure | $51.23M | $69.35M |
| Free cash flow | $659.20M | $923.14M |
| Investing cash flow | -$51.23M | -$69.35M |
| Financing cash flow | -$714.57M | -$886.05M |
| Depreciation & amortization | $79.28M | $69.84M |
| Stock-based compensation | $36.70M | $33.05M |
| Share buybacks | $582.32M | $552.45M |
Free plan shows the latest 2 periods; Pro shows all 17 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.